Add like
Add dislike
Add to saved papers

Multinucleate cell angiohistiocytoma: a distinct entity diagnosable by clinical and histologic features.

BACKGROUND: Multinucleate cell angiohistiocytoma is a newly described entity; examples from the United States have not yet been reported.

OBJECTIVE: Our purpose was to analyze the clinical and histologic features of this entity and confirm or refute its existence.

METHODS: Seven cases were analyzed clinically and by light microscopy.

RESULTS: Multinucleate cell angiohistiocytoma typically occurs in middle-aged women and consists of multiple, grouped, red-brown to violaceous papules that are dome-shaped or flat-topped, roundish and smooth in outline, sharply circumscribed, and occasionally coalescent. Typical sites are the legs, thighs, and backs of hands and fingers. Microscopic features are an increased number of blood vessels (usually capillaries and venules) that are small, rounded, and not well grouped, together with multinucleated histiocyte-like cells with scalloped borders.

CONCLUSION: Multinucleate cell angiohistiocytoma is a distinct entity that is diagnosable clinically and histopathologically.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app